CM Treatment for Alcohol Dependence Using New Technology
Status: | Active, not recruiting |
---|---|
Conditions: | Psychiatric, Psychiatric |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 1/14/2018 |
Start Date: | May 2013 |
End Date: | December 2018 |
Contingency management (CM) is highly efficacious for reducing substance use, and recent data
suggest that reinforcing attendance at treatment can significantly improve treatment
outcomes. Importantly, CM interventions that reinforce attendance are more likely to be
adopted clinically than those that reinforce abstinence. Having objective indicators of
drinking outcomes, nevertheless, is critical for quantifying the benefits of attendance-based
CM treatment in alcohol abusing populations. New technology is now available to gauge alcohol
use in patients' natural environments. The Secure Continuous Remote Alcohol Monitor (SCRAMx®)
continuously monitors alcohol consumption 24 hours a day. As such, it may be ideal for
objective evaluation of alcohol consumption during treatment intervention studies, including
those that involve CM.
In this study, 114 patients participating in community based outpatient treatment programs
for alcohol use disorders will wear SCRAMx for a 12-week period. They will be randomized to
standard care or standard care plus CM, with reinforcement contingent upon attendance at
treatment. The investigators will assess treatment attendance and alcohol use via SCRAMx and
self reports. The investigators expect that patients randomized to the CM intervention will
remain in treatment longer and show reductions in both SCRAMx assessed and self reported
drinking days relative to those randomized to standard care.
suggest that reinforcing attendance at treatment can significantly improve treatment
outcomes. Importantly, CM interventions that reinforce attendance are more likely to be
adopted clinically than those that reinforce abstinence. Having objective indicators of
drinking outcomes, nevertheless, is critical for quantifying the benefits of attendance-based
CM treatment in alcohol abusing populations. New technology is now available to gauge alcohol
use in patients' natural environments. The Secure Continuous Remote Alcohol Monitor (SCRAMx®)
continuously monitors alcohol consumption 24 hours a day. As such, it may be ideal for
objective evaluation of alcohol consumption during treatment intervention studies, including
those that involve CM.
In this study, 114 patients participating in community based outpatient treatment programs
for alcohol use disorders will wear SCRAMx for a 12-week period. They will be randomized to
standard care or standard care plus CM, with reinforcement contingent upon attendance at
treatment. The investigators will assess treatment attendance and alcohol use via SCRAMx and
self reports. The investigators expect that patients randomized to the CM intervention will
remain in treatment longer and show reductions in both SCRAMx assessed and self reported
drinking days relative to those randomized to standard care.
Inclusion Criteria:
- age 18 years or older
- current diagnosis of alcohol use disorder
- able to pass an informed consent quiz
- agree to wear a SCRAMx monitor for 12 weeks
- have a standard, SCRAMx compatible phone line in their home or agree to attend the
clinic at least every other week for data downloads
- agree to sign an off-campus property transfer form and return SCRAMx equipment in 12
weeks
Exclusion Criteria:
- serious, uncontrolled psychiatric illness
- in recovery from pathological gambling
- unstable address
- intend to participate in activities incompatible with SCRAMx in the next 3 months
- are wearing SCRAMx for legal purposes
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials